Skip to main content
. 2019 May 13;9:7276. doi: 10.1038/s41598-019-43532-9

Figure 5.

Figure 5

Effect of 20 days pre-treatment with QTC-4-MeOBnE (0.1 and 1 mg/kg i.g.) on GSK3- β and synaptophysin expression of mice submitted to ICV infusion of STZ (3 mg/kg) or saline. GSK3- β expression in (a) PFC and (b) HC; synaptophysin expression in (c) PFC and (d) HC. Results are expressed as mean ± SEM. (n = 5–6). #p < 0.05 and ##p < 0.01 when compared with the control group. *p < 0.05, **p < 0.01 when compared to STZ group (two-way ANOVA followed by Newman-Keuls test).